Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513994 · ClinicalTrials.gov registry record · Phase 1
MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects
A Phase 1 study, sponsored by MediQuest Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00513994 is a Phase 1 study that has completed, run by MediQuest Therapeutics. The registered enrollment target is 6 participants.
The verdict
NCT00513994, a Phase 1 study, has completed, sponsored by MediQuest Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of the study is to measure how much nitroglycerin or its metabolites may be found in the bloodstream when MQX-503 or an FDA approved Nitroglycerin ointment 2% USP is applied to the skin of healthy subjects.
Interventions
- DRUG Nitroglycerin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00513994
The ClinicalTrials.gov registry entry for NCT00513994 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MediQuest Therapeutics, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nitroglycerin is the first listed.
NCT00513994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00513994 about?
NCT00513994 is a clinical study titled "MQX-503 vs Nitroglycerin Ointment: A Pharmacokinetic Comparison in Normal Subjects". The purpose of the study is to measure how much nitroglycerin or its metabolites may be found in the bloodstream when MQX-503 or an FDA approved Nitroglycerin ointment 2% USP is applied to the skin of healthy subjects.
What is the current status of trial NCT00513994?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2007-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00513994?
The interventions under investigation include: Nitroglycerin (DRUG).
Who is sponsoring clinical trial NCT00513994?
This trial is sponsored by MediQuest Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.